Analysis of Imaging Features From Patients Treated With Brolucizumab in the Post-marketing Setting With Reports of Retinal Vasculitis and/or Retinal Vascular Occlusion
Condition(s):Intraocular Inflammation; Retinal Vascular OcclusionLast Updated:December 20, 2022Completed